National Comprehensive Cancer Network

About NCCN


NCCN Flash Update sent May 27, 2014

NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Pancreatic Adenocarcinoma. These NCCN Guidelines® are currently available as Version 2.2014.

  • For clarification, “nab-paclitaxel” has been changed to “albumin-bound paclitaxel” throughout the guidelines.


  • The Discussion section has been updated to reflect the changes in the algorithm. (MS-1)


*For your reference, the previous update (Version 1.2014) to the NCCN Guidelines for Pancreatic Adenocarcinoma, distributed on January 6, 2014, is available at the following link:



For the complete updated versions of the NCCN Guidelines, the NCCN Drug & Biologics Compendium (NCCN Compendium®), and the NCCN Chemotherapy Order Templates (NCCN Templates®), please visit

To access the NCCN Biomarkers Compendium®, please visit

To view the NCCN Guidelines for Patients®, please visit

Free NCCN Guidelines apps iPhone, iPad, and Android devices are now available! Visit